Multi-Center Evaluation of the Fully Automated PCR-Based Idylla^™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer

• Jérôme Solassol,

  Affiliation Laboratory of Biopathology, Institut du Cancer de Montpellier, Montpellier, France

  ⨯
• Julie Vendrell,

  Affiliation Laboratory of Biopathology, Institut du Cancer de Montpellier, Montpellier, France

  ⨯
• Bruno Märkl,

  Affiliation Institute of Pathology, Klinikum Augsburg, Augsburg, Germany

  ⨯
• Christian Haas,

  Affiliation Institute of Pathology, Klinikum Augsburg, Augsburg, Germany

  ⨯
• Beatriz Bellosillo,

  Affiliation Pathology Department, Hospital del Mar, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

  ⨯
• Clara Montagut,

  Affiliation Oncology Department, Hospital del Mar, IMIM, Barcelona, Spain

  ⨯
• Matthew Smith,

  Affiliation Queen Elizabeth Hospital, Birmingham, United Kingdom

  ⨯
• Brendan O’Sullivan,

  Affiliation Queen Elizabeth Hospital, Birmingham, United Kingdom

  ⨯
• Nicky D’Haene,

  Affiliation Department of Pathology, Hôpital Erasme - Université Libre de Bruxelles, Brussels, Belgium

  ⨯
• Marie Le Mercier,

  Affiliation Department of Pathology, Hôpital Erasme - Université Libre de Bruxelles, Brussels, Belgium

  ⨯
• Morten Grauslund,

  Affiliation Department of Pathology, Rigshospitalet Copenhagen, Copenhagen, Denmark

  ⨯
• Linea Cecilie Melchior,

  Affiliation Department of Pathology, Rigshospitalet Copenhagen, Copenhagen, Denmark

  ⨯
• Emma Burt,

  Affiliation Royal London Hospital, London, United Kingdom

  ⨯
• Finbarr Cotter,

  Affiliation Royal London Hospital, London, United Kingdom

  ⨯
• Daniel Stieber,

  Affiliation Molecular Genetic Unit, Laboratoire National de Santé, Dudelange, Luxembourg

  ⨯
• Fernando de Lander Schmitt,

  Affiliation Department of Pathology, Laboratoire National de Santé, Dudelange, Luxembourg

  ⨯
• Valentina Motta,

  Affiliation Molecular Pathology Unit, Department of Laboratory Medicine, Niguarda Cancer Center, ASST - Grande Ospedale Metropolitano Niguarda, Milan, Italy

  ⨯
• Calogero Lauricella,

  Affiliation Molecular Pathology Unit, Department of Laboratory Medicine, Niguarda Cancer Center, ASST - Grande Ospedale Metropolitano Niguarda, Milan, Italy

  ⨯
• Richard Colling,

  Affiliation Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  ⨯
• Elizabeth Soilleux,

  Affiliation Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

  ⨯
• Matteo Fassan,

  Affiliation Department of Medicine (DIMED), Surgical Pathology Unit, University of Padua, Padua, Italy

  ⨯
• Claudia Mescoli,

  Affiliation Department of Medicine (DIMED), Surgical Pathology Unit, University of Padua, Padua, Italy

  ⨯
• Christine Collin,

  Affiliation Platform of Somatic Tumor Molecular Genetics, Centre Hospitalier Régional Universitaire de Tours, Tours, France

  ⨯
• Jean-Christophe Pagès,

  Affiliation Platform of Somatic Tumor Molecular Genetics, Centre Hospitalier Régional Universitaire de Tours, Tours, France

  ⨯
•  [ ... ],
• Peter Sillekens

  * E-mail: psillekens@biocartis.com

  Affiliation Biocartis, Mechelen, Belgium

  ⨯
• [ view all ]
• [ view less ]